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The monocarboxylate transporter Mct10 (Slc16a10; T-type amino acid transporter) facilitates the
cellular transport of thyroid hormone (TH) and shows an overlapping expression with the well-
established TH transporterMct8. BecauseMct8 deficiency is associatedwith distinct tissue-specific
alterations in TH transport and metabolism, we speculated that Mct10 inactivation may compro-
mise the tissue-specific TH homeostasis as well. However, analysis of Mct10 knockout (ko) mice
revealed normal serum TH levels and tissue TH content in contrast to Mct8 ko mice that are
characterized by high serum T3, low serum T4, decreased brain TH content, and increased tissue TH
concentrations in the liver, kidneys, and thyroid gland. Surprisingly, mice deficient in both TH
transporters (Mct10/Mct8 double knockout [dko] mice) showed normal serum T4 levels in the
presenceofelevated serumT3, indicating that theadditional inactivationofMct10partially rescues
the phenotype of Mct8 ko mice. As a consequence of the normal serum T4, brain T4 content and
hypothalamic TRH expression were found to be normalized in the Mct10/Mct8 dko mice. In con-
trast, thehyperthyroid situation in liver, kidneys, and thyroidglandofMct8 komicewas evenmore
severe in Mct10/Mct8 dko animals, suggesting that in these organs, both transporters contribute
to the TH efflux. In summary, our data indicate thatMct10 indeed participates in tissue-specific TH
transport and also contributes to the generation of the unusual serum TH profile characteristic for
Mct8 deficiency. (Endocrinology 155: 315–325, 2014)
Thyroid hormone (TH) action and metabolism requirethe transportofTHacross cellmembranesbecauseTH
receptors aswell as theTHmetabolizing deiodinases exert
their action intracellularly. Until now, several proteins
have been identified that can facilitate TH passage in and
out of cells (1). Among them, the monocarboxylate trans-
porter 8 (MCT8) has received greatest attention because
MCT8 only accepts TH as substrate, thereby exhibiting
the most restricted substrate specificity (2). Moreover, in-
activating mutations in the X-linked MCT8 gene are as-
sociated with a severe form of psychomotor retardation,
also known asAllan-Herndon-Dudley syndrome (3–5). In
addition to pronounced neurologic symptoms andmuscle
hypotonia, patients with inactive MCT8 exhibit very un-
usual circulating TH values with highly elevated T3 in the
presence of low to normal T4 (6). These endocrine abnor-
malities are fully replicated in Mct8 knockout (ko) ani-
mals (7, 8). In contrast, Mct8 ko mice do not show any
overt neurologic abnormalities although the uptake of T3
into the central nervous system (CNS) is strongly impaired
in the absence ofMct8 (8–10). However, T4 can still enter
the CNS in these animals by taking advantage of the T4-
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specific transporter Oatp1c1 that in rodents is highly ex-
pressed in the choroid plexus and in blood-brain-barrier
(BBB) endothelial cells (11, 12) but absent in BBB endo-
thelial cells of primates (13) and only weakly expressed in
the human CNS (14). That Mct8 and Oatp1c1 indeed act
together in providing TH access to the brain could only
recentlybedemonstratedby theanalysis ofMct8/Oatp1c1
double knockout (dko) mice. These animals show an
abolished uptake of both T3 and T4 into the brain (15),
indicating that the lack of one transporter might be
compensated by the presence of another carrier present
in the same cell.
In addition to its crucial role in the CNS, human and
mouseMct8 iswidely expressed inmanyperipheral tissues
such as liver, kidney, and thyroid where it may also con-
tribute substantially to tissue-specific TH transport. Anal-
ysis of the tissue TH content revealed strongly increased
TH concentrations in the kidneys and thyroid gland of
Mct8 ko mice, suggesting that Mct8 localized at the ba-
solateral membrane preferentially acts as a TH efflux sys-
tem (16–18).Moreover, highly elevated type 1 deiodinase
(D1) activities in liver and kidneys indicate a thyrotoxic
state of these organs in the absence of Mct8 (7, 8, 17).
Consequently, in addition to Mct8, at least one other TH
transporter must be present that eventually facilitates the
access of TH into these cells.
As a putative candidate we considered the monocar-
boxylate transporter 10 (Mct10, also known as T-type
amino acid transporter TAT1) as another transporter that
may significantly contribute to TH transport in vivo.
Among all members of the monocarboxylate transporter
family Mct8 and Mct10 are most closely related (19).
Moreover,Mct10was demonstrated not only to facilitate
the transport of Phe, Tyr, Trp, andDopa (19–21) but also
to accept iodothyronines as substrates (22). Expression
studies in mice revealed the localization of Mct10 pro-
tein at the basolateral membrane of small intestine ep-
ithelial cells, of renal proximal tubule cells, and in
perivenous hepatocytes (19, 23), indicating an overlap-
ping expression pattern of Mct10 and Mct8 in kidneys
and liver (18, 19).
The physiological relevance of Mct10 for amino acid
homeostasiswas recently addressed in studiesofMct10ko
animals (24). LikeMct8komice,Mct10-deficient animals
appear normal with respect to growth and fertility, and
they also do not exhibit overt neurologic symptoms. De-
termination of aromatic amino acid concentrations, how-
ever, revealed increased levels in plasma, muscle, and kid-
neys whereas liver aromatic amino acid content remained
unaltered. To which degree TH transport and tissue con-
centrations are affected by the absence of Mct10 has not
yet been addressed.
Here, we report on our findings regarding TH trans-
port, metabolism, and action in Mct10 ko mice as well as
in animals lacking both transporters, Mct10 and Mct8
(Mct10/Mct8 dko mice). Whereas TH homeostasis was
found to be rather unaffected by the absence of Mct10,
Mct10/Mct8 dko animals exhibited distinct alterations in
tissueTHcontent thatwere strikingly different from those
changes found inMct8 ko animals.Most intriguingly, low
serumandbrainT4 concentrations, a hallmarkofMct8ko
mice, were normalized in Mct10/Mct8 dko animals, sug-
gesting that the additional inactivation ofMct10 partially
rescues the TH abnormalities characteristic for Mct8
deficiency.
Materials and Methods
Animals
Female Mct8 / mice were obtained from Deltagen and
used to generate Mct8 ko mice as previously described (8). The
Mct10 ko mouse was generated by Ingenium Pharmaceuticals
AG. By N-ethyl-nitrosourea mutagenesis, a nonsense mutation
was introduced into the Mct10 gene that leads to a premature
stop codon at amino acid 88 (Y88X). Absence ofMct10 expres-
sion in these animals was previously confirmed by immunoflu-
orescence and mRNA analysis (24). Genotyping was performed
by PCR (35 cycles, 30 seconds at 95°C, 60 seconds at 55°C, and
30 seconds at 72°C) using the following primers (Frw: 5-GGG
ACC CTC GGA TGT CTC-3, Rev: 5-CAC CCT CCC AAC
ACA AGA-3). The PCR product was then subjected to enzy-
matic restriction using DdeI (2 hours at 37°C) in order to detect
the point mutation in theMct10 mutated allele after gel electro-
phoresis. Expected sizeof theproducts after digestion: 320bp for
the wild-type (Wt) allele and 170 bp for the mutant allele.
Mct10/Mct8 dko mice were produced by mating the respec-
tive single knockout mice and consecutively Mct10/Mct8
heterozygous animals. All mice used in these studies were males
on aC57BL/6background, andall animal studieswere approved
by theThüringer Landesamt für Lebensmittelsicherheit undVer-
braucherschutz (Thüringen, Bad Langensalza, Germany). De-
tails concerning tissue collection are provided as supplemental
data.
Serum TH levels were determined by in-house RIAs as re-
ported elsewhere (25, 26). Serum alkaline phosphatase and cho-
lesterol concentrations were determined by Laboklin. Tissue T4
and T3 content was analyzed after extraction as described pre-
viously (27). TSH serum levels were determined using a double-
antibody precipitation RIA as published previously (28, 29) and
described briefly in the supplemental data.
In situ hybridization (ISH)
The list of cDNA fragments used for the generation of 35S-
uridine 5-triphosphate (Hartmann Analytik) radiolabeled or
Digoxigenin-UTP-labeled riboprobes by in vitro transcription is
provided in Supplemental Table 1 published on The Endocrine
Society’s Journals Online web site at http://endo.endojournal-
s.org. ISH was carried out as published previously (30) and
briefly described in the supplemental data. Experiments carried
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out using the respective sense probes did not produce any hy-
bridization signals (data not shown).
Quantitative real-time PCR (qPCR)
Total RNA from pituitary and thyroid was isolated using
RNeasy Lipid Tissue Mini Kit (QIAGEN) and from liver and
kidney by using Nucleospin RNA II Kit (Macherey-Nagel) ac-
cording to the manufacturer‘s instructions and stored at80 C.
Synthesis of cDNA was performed using the Transcriptor High
Fidelity cDNA Synthesis Kit (Roche). To exclude the presence of
genomic DNA, one sample without reverse transcriptase was
included aswell. qPCRwas performed using the iQ SYBRGreen
Supermix and the Multicolor Real-Time PCR Detection System
(Bio-Rad Laboratories). At least 5 samples per genotype were
subjected to theanalysis.Cyclophilinwasusedas ahousekeeping
gene for normalization. A list of primers used for the generation
of the respective PCR fragments is provided in Supplemental
Table 2.
Thyroid histology
For morphologic analysis, thyroid glands were isolated and
fixed in phosphate-buffered 4% formalin at room temperature
overnight and rinsed in PBS and increasing ethanol concentra-
tions. Thyroids were embedded in paraffin and cut on a mi-
crotome. In order to quantify the thyroid follicle areas, 5-m
thick paraffin sections from at least 3 thyroids per genotype and
time point were counterstained with hematoxylin/eosin accord-
ing to standard protocols. Using 3–4 sections of each thyroid
gland, the area of all follicles was determined using the open
source ImageJ software (NIH, Bethesda, Maryland).
For Ki-67 immunostaining, thyroid paraffin sections were
deparaffinized and treated with 1% NaOH and 1% H2O2 to
block the endogenous peroxidase activity. Then, sections were
boiled for 20 minutes in citrate buffer (pH 6.0) to perform an-
tigen retrieval. After blocking in 0.2%PBS-Tween 20 containing
10% normal goat serum at room temperature for 1 hour, sec-
tions were incubated with a primary antibody against Ki-67 (1:
300; monoclonal rat; eBioscience) at 4°C overnight, and then
washed in PBS and incubated for 1 hour with a biotinylated
secondary antibody (Vector Laboratories). For signal detection,
sections were treated 30 minutes with ABC Elite reagent (Vec-
tastain) and subsequently stained with diaminobenzidine/per-
oxide (SurModics).
In vivo TH transport studies
Adult animals (3–5 animals per genotype and time point)
were injected ip with 2.5  106 cpm [125I]T4 (PerkinElmer).
After 1 hour, 3 hours, and 5 hours animals were anesthetized
with isoflurane, blood samples were collected, and subsequently
the mice were perfused with saline. After removal of the organs,
the amount of radioactivity in the respective tissuewasmeasured
by an automatic -counter. Results were presented as the per-
centage of the injected dose per g tissue.
Statistical analysis
If not stated otherwise, the values represent mean  SEM.
Statistical significance between groups was determined by two-
way ANOVA followed by a post hoc test (Bonferroni). P .05
was considered to be statistically significant.
Results
For studying the functional significance of Mct10 in TH
homeostasis,Mct10//Mct8/ femalemiceweremated
with Mct10//Mct8/y male mice. Because Mct8 is lo-
calized on the X chromosome, male offspring are either
Mct10//Mct8/y ( Mct10 ko) or Mct10//Mct8/y
(Mct10/Mct8 dko). In addition, male Wt and Mct8 ko
mice were included in the analysis that were generated by
mating heterozygous Mct8 females with Mct8 ko males.
All breeding pairs produced offspring with the expected
Mendelian ratio excluding prenatal lethality. Pups of all
genotypes developed normally and did not show any signs
of growth retardation. Animals of all genotypes and both
sexes were fertile and phenotypically normal.
Analysis of serum TH profile and activity of the
hypothalamus-pituitary system
Analysis of serum T4 levels of 21-day-old (P21) and
2.5-months-old animals revealed no significant differ-
ences between Wt and Mct10 ko mice whereas a slight
decrease in serum T3 could be observed inMct10 ko mice
at P21 but not at the age of 2.5 months. In comparison,
Mct8 ko mice exhibited the expected abnormalities with
decreased serum T4 and increased serum T3 that even in-
creased with age (Figure 1). Similarly elevated serum T3
levels could also be observed inMct10/Mct8 dko animals.
Interestingly,Mct10/Mct8 dko showed only amild reduc-
tion in serum T4 at P21 and even similar levels as Wt and
Mct10 ko mice at the age of 2.5 months. These data in-
dicate that the additional inactivation of Mct10 partially
rescues the TH abnormalities of Mct8-deficient mice.
Howdo the changes inTHserumprofile affect the tissue-
specific TH homeostasis? Determination of the TH content
in forebrains isolated from 2.5-month-old animals revealed
normalT3 andT4values inMct10komicewhereasMct8ko
mice exhibited an approximately 50% reduction in both T3
and T4 concentrations (Figure 2A). Interestingly, TH fore-
brain contentwasonlymildlydecreased inMct10/Mct8dko
mice, indicatingagainapartial rescueof theMct8phenotype
in the double-mutant animals.
In order to assess the impact of the combined transporter
deficiencyon the activity of the hypothalamus-pituitary-thy-
roid axis, we analyzed TRH transcript levels in the paraven-
tricular hypothalamic nucleus as well as TSH transcript lev-
els in pituitaries by nonradioactive ISH. As shown in Figure
2B, signal intensities were not different between Wt and
Mct10 ko mice, suggesting rather normal TRH and TSH
expression levels in the absence ofMct10. In agreementwith
previous findings,Mct8komice showed increasedTRHand
TSH transcript levels, indicating a hypothyroid situation in
bothhypothalamus andpituitary. InMct10/Mct8dkomice,
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TSH levels were found to be similarly elevated. However,
hypothalamic TRH levels were not obviously up-regulated
in these double-mutant animals.
Enhanced pituitary TSH expression in Mct8 ko and
Mct10/Mct8 dko mice could be further confirmed by
quantitative real-time PCR (qPCR) (Figure 2C). Tran-
script levels of D2 and GHwere not altered in any animal
group. Intriguingly, prolactin transcript levels were found
to be highly elevated in Mct8 ko mice. This increase in
pituitary prolactin may be a consequence of the elevated
hypothalamic TRH levels because TRH acts also on lac-
totrophs, thereby stimulating prolactin synthesis (31, 32).
Impact of combined Mct10/Mct8 deficiency on
thyroid gland activity
Next, we addressed the consequences of a combined
Mct10/Mct8 deficiency on thyroid function andmorphol-
ogy. Both Mct10 and Mct8 are ex-
pressed in follicular epithelial cells as
demonstrated by radioactive ISH
(Figure 3A) and qPCR analysis (Sup-
plemental Figure 1A) using thyroid
glands from 2.5-month-old animals.
Neither inMct8 ko nor inMct10 ko
mice could a compensatory up-reg-
ulation of each other’s expression be
noted. Inactivation of Mct10 or
Mct8 alone also did not affect tran-
script levels of deiodinases D1 and
D2aswell as of genes involved inTH
production, whereas the combined
Mct10/Mct8 deficiency resulted in
a significant increase in sodium/io-
dide symporter, thyroid peroxi-
dase, and TSH receptor mRNA ex-
pression, suggesting that TH
production may be stimulated in
the absence of both transporters
(Figure 3B).
In order to address this question
wedetermined thyroidalTHconcen-
trations in2.5-month-oldanimalsby
measuring non-thyroglobulin-
bound ( free) THconcentrations as
well as total TH that reflect both free
as well as thyroglobulin-bound TH.
As depicted in Figure 3C, Mct10 ko
mice did not show any alterations in
thyroidal TH content whereas Mct8
ko animals exhibited significantly el-
evated free and total TH levels in
agreement with previous observa-
tions (16, 18). In thyroid glands of
Mct10/Mct8 dko animals, free and total T4 content were
1.8-fold and 1.9-fold elevated compared with levels in
Mct8 ko mice. Free and total T3 content were found to be
even further elevated because Mct10/Mct8 dko mice ex-
hibited a 2.7-fold increase in free T3 and a 2.5-fold rise in
total T3 compared with the values measured in Mct8 ko
animals. Obviously, Mct10/Mct8 dko mice show a much
higher accumulationofTH in the thyroid gland thanMct8
ko animals.
We wondered whether the strong up-regulation in thy-
roidal TH content of Mct10/Mct8 dko animals was re-
flected by an increase in follicle size. We therefore quan-
tified the size of all follicles using 3–4 sections of each
thyroid gland derived from animals of different age and
genotype (Figure 4A). In agreement with our previous ob-
servations (16), we found a moderate increase (1.5- to
Figure 1. Abnormal serum TH profile of Mct8 ko mice is partially normalized in Mct10/Mct8-
deficient animals A, Serum TH concentrations were determined at P21 (n  7–10 per genotype)
and at the age of 2.5 months (n  5 per genotype). Whereas Mct10 (M10) ko animals showed
rather normal serum TH levels, Mct10/Mct8 dko (M10/M8 dko) mice exhibited the same
abnormally elevated serum T3 levels as Mct8 (M8) ko animals. Unexpectedly, serum T4
concentrations were significantly higher in the M10/M8 dko animals compared with Mct8 ko
mice. Consequently, the T3/T4 ratio is less disturbed in the absence of Mct10 and Mct8 as
illustrated in panel B. *, P  .05; **, P  .005; ***, P  .001.
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2-fold) in follicle area in Mct8 ko mice. Mct10/Mct8-
deficient animals tended to have even larger follicles
than Mct8 ko mice although statistical significance
could only be reached at 12 months of age. This differ-
ence between Mct8 ko and Mct10/Mct8 dko animals
could not be explained by an enhanced TSH stimulation
of the thyroid gland becauseMct8 andMct10/Mct8 dko
animals exhibited similarly elevated serum TSH levels
compared with Wt and Mct10 ko mice (Figure 4B).
By examining hematoxylin/eosin-stained thyroid
gland sections, we observed another abnormality that
was already described forMct8 ko mice (33). At the age
of 12 months, 63% of Mct8 ko
mice and 20% of Mct10/Mct8 dko
mice exhibited typical features of
papillary microcarcinomas as evi-
denced by papillary-like outgrowth
and enlarged as well as milk glass-
like nuclei (Figure 4C). Moreover,
a high number of proliferating thy-
roid follicle cells could be detected
in these areas by Ki-67 immuno-
staining. We were not able to find
either any histologic signs ofmicro-
carcinomas on sections derived
from younger animals or from
12-month-old Wt or Mct10 ko
animals.
Because the expression of tumor
marker proteins may be already ele-
vated at an early age, we performed
qPCR analysis with thyroid glands
of 2.5-month-old animals in order to
determine the transcript levels of the
pituitary tumor-transforming gene
(Pttg1), Pttg1-binding factor (PBF)
as well as of galectin-3 (Gal3). Pttg1
and PBF have been described as po-
tent protooncogenes correlating
with thyroid carcinomas (34, 35)
whereas Gal3 is a well-established
biomarker for thyroid carcinomas
(36). As depicted in Figure 4D, nei-
ther Pttg1 nor PBF transcript levels
were found to be elevated in Mct8-
and/or Mct10-deficient animals.
However, Gal3 mRNA levels were
significantly higher in 2.5-month-
old Mct8 ko mice and even more so
in Mct10/Mct8-deficient animals,
indicating an early onset of thyroidal
derangements.
Renal TH transport and metabolism in Mct10- and
Mct8-deficient animals
Mct10andMct8arehighly expressed in renal proximal
tubule cells in which both transporters are localized at the
basolateral membrane (17, 19). Inactivation of either
Mct8 orMct10 did not affect each other’s transcript levels
as illustrated by ISH and qPCR analysis (Supplemental
Figure 1B). Determination of renal T4 and T3 content in
2.5-month-old animals revealed a 1.8-fold and a 5.3-fold
increase in Mct8 ko mice compared with Wt littermates,
whereas the tissue TH content in kidneys of Mct10 ko
Figure 2. Consequences of Mct10 and Mct10/Mct8 deficiency on the TH status in brain and
pituitary A, TH tissue content was measured in forebrain extracts of 2.5-month-old animals (n 
5 per genotype) and revealed normal concentrations in Mct10 (M10) ko mice. In contrast, T4 and
T3 concentrations were significantly decreased in forebrains of Mct8 (M8) ko mice but to a lesser
extent in Mct10/Mct8 (M10/M8) dko animals. B, Nonradioactive ISH studies were performed on
brain and pituitary cryosections from P21-old animals (n  3 per genotype) in order to visualize
hypothalamic TRH (upper row) and pituitary TSH transcript levels (lower row), respectively. Wt
and Mct10 ko animals showed a similar hybridization pattern, indicating no alterations in the
respective transcript levels. As expected, TRH and TSH ISH intensities were visibly elevated in
Mct8 ko mice whereas Mct10/Mct8 dko mice showed only elevated TSH but rather normal
hypothalamic TRH signal intensities. Scale bar, 200 m for TRH and 1 mm for TSH. C, qPCR
analysis using pituitaries derived from 2.5-month-old animals (n  5 per genotype) confirmed the
observations from the ISH studies and revealed a similar rise in TSH transcript levels in Mct8 ko
and Mct10/Mct8 dko mice. Type 2 deiodinase (D2) and GH transcript levels were not altered by
Mct8 and/or Mct10 deficiency. Interestingly, prolactin expression showed a 2.2-fold increase in
the pituitaries of Mct8 ko mice compared with Wt littermates. *, P  .05; **, P  .005; ***,
P  .001. AU, arbitrary units.
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mice was not altered (Figure 5A). In-
triguingly, significantly higher TH
concentrationswere observed in kid-
neys ofMct10/Mct8 dkomicewith a
2.6-fold elevation in T4 values and a
9.4-fold increase in T3 levels com-
pared with Wt mice. Obviously, the
additional inactivation of Mct10
further enhanced the accumulation
of TH in the kidneys of Mct8 ko
mice.
In line with the increased renal T3
values, determination of kidney D1
expression by ISH and qPCR re-
vealed highly elevated D1 transcript
levels inMct8koanimalswhereasno
changes in renalD1expression could
be observed in Mct10 ko mice (Fig-
ure 5, B and C). Again, Mct10/Mct8
dko animals showed the most pro-
nounced alterations with a 3.8-fold
rise in D1 compared with the 2.5-
fold elevation in D1 mRNA levels
found in Mct8 ko mice.
Because we recently found an in-
creased renal accumulation of pe-
ripherally injected T4 in Mct8 ko
mice (17), we wondered whether
Mct10/Mct8 dko animals would
show an even higher renal uptake of
T4 thanMct8 ko mice. We therefore
performed in vivo transport studies
by injecting adult animals ip with
125I-labeled T4. As illustrated in Fig-
ure 5D,Mct10 ko mice showed sim-
ilar amounts of renal radioactivity as
Wt animals. In comparison, renal ra-
dioactivitywas significantly elevated
in both Mct8 ko and Mct10/Mct8
dkomice at all analyzed time points,
suggesting that renal T4 uptake was
similarly stimulated in Mct8 ko and
Mct10/Mct8 dko mice.
Analysis of TH metabolism and
transport in the liver of Mct10-
and Mct8-deficient mice
In addition to the kidneys, Mct10
and Mct8 show also an overlapping
expression in the liver as demon-
strated by ISH (Supplemental Figure
1C). Whereas Mct10 deficiency did
Figure 3. Consequences of Mct10 and/or Mct8 deficiency on the activity of the thyroid gland
A, Radioactive ISH studies were performed on thyroid sections from 2.5-month-old animals (n 
3 per genotype) and revealed an overlapping expression of Mct8 and Mct10 in follicular epithelial
cells in Wt animals. Inactivation of Mct8 or Mct10 did not visibly affect the transcript levels of the
other TH transporter. Scale bar, 50 m. B, Thyroidal expression profiling by qPCR showed
significantly elevated transcript levels of the sodium/iodide symporter (Nis), thyroid peroxidase
(TPO), and TSH receptor (TSH-R) in Mct10/Mct8 dko mice compared with Wt animal whereas
neither Mct8 ko nor Mct10 ko animals revealed any significant alterations (n  7 per genotype;
age: 2.5 months). §, P  .005; #, P  .001. C, Non-thyroglobulin (Tg)-bound ( free) TH and
total tissue TH concentrations were measured in thyroid glands of 2.5-month-old animals (n  5
per genotype). Whereas Mct10 ko mice did not show any alterations, Mct8 ko mice displayed
significantly elevated non-Tg-bound and total TH concentrations in the thyroid gland.
Interestingly, these values were even further elevated in Mct10/Mct8 dko mice with the highest
rise in non-Tg-bound T3 (12-fold higher than Wt levels). *, P  .05; **, P  .005; ***, P  .001.
AU, arbitrary units.
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not affect hepatic Mct8 transcript levels, ISH and qPCR
revealed a slight increase in hepatic Mct10 mRNA levels
in Mct8 ko animals. Neither liver TH content nor D1
mRNA levels were altered in Mct10 ko mice (Figure 6, A
and B). In comparison, Mct8 ko mice displayed normal
hepatic T4 levels but a 3.7-fold rise in liver T3 levels. Strik-
ingly, Mct10/Mct8 dko mice showed a 1.6-fold elevation
in liver T4 and a 5-fold rise in hepatic T3 levels. In agree-
ment with the elevated liver T3 values, ISH and qPCR
analysis revealed increased hepatic transcript levels for the
T3-regulated genes D1 and GPD2 in Mct8 ko mice and
even higher levels inMct10/Mct8 dkomice (Figure 5B and
Supplemental Figure 1,DandE). In vivo transport studies,
however, didnot exhibit anyalterations inhepatic [125I]T4
uptake between Wt, Mct10 ko, and Mct8 ko mice. Only
in liver samples ofMct10/Mct8 dko animals didwe detect
a significant increase in radioactivity 1 and 3 hours after
[125I]T4 ip injections (Figure 6C).
Finally, we analyzed established serum markers of TH
action and found significantly increased concentrations of
alkaline phosphatase as well as significantly reduced
amounts of cholesterol in the serum of Mct8 ko and
Mct10/Mct8 dko animals (Figure 6D). These changes in
serum parameters are indicative of a pronounced hepatic
thyrotoxicosis and have already been reported for Mct8
ko mice (7, 37).
Discussion
Both in humans and mice, Mct8 deficiency is associated
with robust alterations in the TH serum profile charac-
Figure 4. Follicular abnormalities in Mct8-deficient thyroid glands A, Follicle areas were quantified with ImageJ using hematoxylin/eosin (H/E)-
stained thyroid paraffin sections derived from adult animals (at least 3 animals per genotype and time point). A significant increase in follicle size
was found only in Mct8 ko and Mct10/Mct8 dko animals. B, Serum TSH levels were determined in 12-month-old animals (n  6 per genotype)
and revealed similarly elevated concentrations in Mct8 ko and Mct10/Mct8 dko mice. C, Papillary microcarcinoma-H/E stained thyroid sections
from 12-month-old Mct8 ko animals that showed papillary-like outgrowth, enlarged nuclei (asterisk), and milk glass-like nuclei (arrow). Enlarged
follicles are visible around this lesion. Immunostaining of thyroid sections with the proliferation marker Ki-67 revealed a high number of mitotic
cells within the papillary-like structures. Scale bar, 50 m. D, Thyroidal expression of the different tumor-associated markers was determined in
2.5-month-old animals (n  7 per genotype) by qPCR and revealed significantly elevated Galectin-3 (Gal3) in Mct8 ko and Mct10/Mct8 dko mice.
Pttg1, pituitary tumor-transforming gene 1; *, P  .05; **, P  .005; ***, P  .001. AU, arbitrary units.
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terized by high serum T3 in the presence of rather low
circulatingT4 serum levels. Although the exact underlying
pathogenic mechanisms are still not fully understood,
studies ofMct8 komousemutants had shed some light on
this issue. Obviously, a disturbed TH homeostasis in sev-
eral tissues contributes to thegenerationof the imbalanced
T3:T4 ratio. In the absence ofMct8, the thyroid gland itself
is affected because, despite an increase in thyroidal TH
content, less T4 is secreted into the bloodstreamuponTSH
stimulation. This observation indicates that Mct8 fulfils
an important T4 export function in the thyroid (16, 18). In
the liver and kidneys, high D1 activities lead to an in-
creased T4 to T3 conversion that in turn seems to contrib-
ute significantly to the elevated serum T3 levels (38). Fi-
nally andmost surprisingly, absence ofMct8 is associated
with an elevated transport of T4 and
T3 into the kidneys that, in turn,
leads to a thyrotoxic state. Based on
these findings, it is tempting to spec-
ulate that in peripheral organs such
as liver, thyroid, and kidneys, Mct8
may preferentially act as a T4 efflux
systemwhereas the import/export of
T3 may still be ensured by other TH
transporters. This scenario is differ-
ent from the situation in the murine
brain in whichMct8 deficiency is as-
sociated with an impaired transport
of T3 across the BBB whereas T4 up-
take was found to be only mildly
compromised (8, 9). The latter ob-
servation can be explained by the
presence of the T4-selective trans-
porter Oatp1c1, which can partially
compensate for the absence of Mct8
in the mouse CNS. Indeed, the gen-
eration and analysis of Mct8/
Oatp1c1 dko mice underscored the
physiologic significance of this TH
transporter pair as the passage ofTH
into the brain was highly diminished
(15).However, becauseOatp1c1 ex-
pression is restricted to the CNS, it
remains to be elucidated which
transporters may functionally coop-
erate with Mct8 in mediating TH
transport in peripheral tissues.
Here, we followed the hypothesis
that Mct10, the T-type amino acid
transporter TAT1, functions as a
transporter for TH as well. In vitro
transport studies using transfected
COS1 cells already revealed that human MCT10 trans-
ports T3 at least as efficiently as humanMCT8 in and out
of cells whereas it is less active toward the transport of T4
(22). In mice, Mct10 shows an overlapping expression
with Mct8 in organs such as liver, kidney, and thyroid in
which Mct10 may act together with Mct8 in mediating
cellular TH passage.
Unexpectedly, our analysis ofMct10-deficient animals
did not reveal any abnormalities in serumTH levels or TH
homeostasis, questioning the physiologic significance of
Mct10 as a prominent TH transporter in vivo. However,
this conclusion may be misleading and the “real” contri-
bution of Mct10 in TH transport may be masked due to
the presence of Mct8, which might be able to compensate
for the absence of Mct10 inMct10 ko mice. We therefore
Figure 5. Excessive TH levels in the kidneys of Mct8 ko and Mct10/Mct8 dko mice A, The tissue
concentrations of T4 and T3 were determined in kidneys of 2.5-month-old animals (n  5 per
genotype) and revealed highest levels in the absence of both TH transporters (Mct10/Mct8 dko).
B, Radioactive ISH analysis demonstrated elevated type 1 deiodinase (D1) transcript levels in the
renal cortex of Mct8 ko and Mct10/Mct8 dko mice and highest D1-specific signal intensities in
the renal outer medulla of Mct10/Mct8-deficient animals. Scale bar, 1 mm. C, In agreement with
the ISH data, qPCR analysis showed strongly elevated D1 transcript levels in Mct8 ko mice and a
further increase in Mct10/Mct8 dko animals (n  7 per genotype, P21). **, P  .005; ***, P 
.001. D, Quantification of renal radioactivity following the ip injection of [125I]T4 revealed a
similar increase over time in Mct8 ko (gray triangle) and Mct10/Mct8 dko (open square) animals
whereas the uptake of [125I]T4 in Mct10 ko (gray square) mice was similar to that of Wt (black
diamond) animals. #, P  .05 for Mct8 ko vs Wt; §, P  .001 for Mct10/Mct8 dko vs Wt.
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generatedandanalyzedmousemutants thatweredeficient
in both TH transporters and, indeed, we found robust
alterations in these Mct10/Mct8 dko mice that by far ex-
ceeded those characteristic changes in tissue TH homeo-
stasis caused by Mct8 deficiency alone. In particular, TH
tissue concentrations were highly elevated in the liver and
kidney of Mct10/Mct8 dko mice, indicating that these
organs are even more “hyperthyroid” in the absence of
both TH transporters than in the single Mct8 ko mice.
Intriguingly, in vivo transport studies did not reveal any
differences in renal and hepatic T4 uptake between Mct8
ko and Mct10/Mct8 dko mice. It is therefore tempting to
speculate that Mct8 and Mct10 are
primarily involved in facilitating the
efflux of THwhereas other unidirec-
tional transport systems are critical
for the import of TH, particularly
into the liver and kidney.
In addition to liver and kidney,
the thyroid gland appears to bemore
severely affected if both TH trans-
porters aremissing. Total THaswell
as non-thyroglobulin-bound TH
concentrations in the thyroid glands
were approximately 2- to 3-fold
higher in Mct10/Mct8 dko mice
compared with the already elevated
thyroidal TH levels ofMct8 komice.
This remarkable rise may reflect, at
least in part, a stimulated thyroidal
TH production because transcript
levels of sodium/iodide symporter,
thyroid peroxidase, and TSH-recep-
tor were found to be highly elevated
specifically inMct10/Mct8 dkomice
whereas serum TSH levels were sim-
ilarly increased in Mct8 ko and
Mct10/Mct8 dkomice. On the other
hand, the pronounced accumulation
of particularly free T3 in the thyroid
glands ofMct10/Mct8dkomice sug-
gests that, in addition to a compro-
misedT4 secretiondue to the absence
of Mct8, the additional lack of
Mct10 is associated with a further
restriction in T3 efflux.
Previous histologic studies have
revealed that starting from the age of
6 months, Mct8 ko mice gradually
developed papillary hyperplasia and
nuclear features consistentwith pap-
illary thyroid carcinoma (PTC) (33).
Wirth et al (33) also reported pronounced thyroidal ab-
normalities including hyperplastic nodules and microfol-
licular structures in one patient with MCT8 mutation.
Here, we could detect similar morphologic alterations in
12-month-old animals with a higher incidence inMct8 ko
mice compared with Mct10/Mct8 dko mice. Moreover,
we could detect highly increased galectin-3 transcript lev-
els in thyroid glands of Mct8 ko and Mct10/Mct8 dko
animals already at 2.5 months of age, indicating that the
onset of the papillary changes occurs at a rather young age
but progresses very slowly. Whether the chronically in-
creased serum TSH levels drives the development of the
Figure 6. Accumulation of T4 and T3 in the liver of Mct10/Mct8 dko mice A, Determination of
hepatic TH concentrations revealed highly elevated T3 and T4 levels of Mct10/Mct8 dko mice
whereas Mct8 ko mice only exhibited an increase in hepatic T3 (n  5 per genotype; 2.5 months
old). B, Both Mct8 ko and Mct10/Mct8 dko mice showed a rise in liver D1 transcript levels as
assessed by qPCR analysis (n  7 per genotype; P21). C, After the injection of 125I-labeled T4,
animals (n  3–5 per time point and genotype; 2–6 months old) were perfused with saline at
given time points. Amounts of radioactivity in liver samples were quantified and presented as the
percentage of injected dose normalized to the respective tissue weight. No differences in hepatic
accumulation of radioactivity could be observed between the different genotypes. #, P  .005
for Mct10/Mct8 dko (open square) vs Wt (black diamond); light gray triangle, Mct8 ko; gray
square, Mct10 ko. D, Quantification of serum parameters demonstrated increased alkaline
phosphatase and decreased cholesterol concentrations in Mct8 ko and Mct10/Mct8 dko mice
(n  5 per genotype; 6–8 months old). These alterations are indications for a thyrotoxic state of
the liver. *, P  .05; **, P  .005; ***, P  .001. AU, arbitrary units.
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PTC or additional cell-intrinsic factors promote follicular
abnormalities duringMct8deficiency is currently amatter
of speculation, and more sophisticated animal models are
required to answer this question.
Themost puzzling observation was the finding that the
additional inactivation ofMct10 inMct8 komice leads to
a normalization of the low serum T4 concentrations with-
out normalizing the high serum T3 levels. The normal se-
rum T4 appears to have beneficial effects on the CNS be-
cause brain TH content was less severely decreased and,
consequently, hypothalamic TRHexpression less affected
in Mct10/Mct8 dko mice compared with Mct8 ko ani-
mals. Because Mct10 is absent from the murine BBB and
Mct8 plays only aminor role in facilitating T4 uptake into
the mouse CNS (8), it may not be too surprising that due
to the rise in serum T4 inMct10/Mct8 dko mice, brain T4
content is higher in these animals comparedwithMct8 ko
mice that show low serum T4 and consequently decreased
T4 brain content.
Why the drop in serum T4 in Mct8-deficient animals
can be prevented by the additional inactivation of Mct10
remains to be investigated.We and others have speculated
that the low serum T4 levels in Mct8 ko mice are due to a
decreased thyroidal T4 secretion aswell as an increased T4
to T3 conversion mediated by D1 in liver and kidneys
(16–18). In support of this hypothesis, Mct8/D1 dko an-
imals showed rather normal serum TH levels, suggesting
that the rise in hepatic and renalD1 expression inMct8 ko
mice contributes significantly to the odd T3/T4 serum pro-
file (38). We also proposed that, in the absence of Mct8,
the kidney acts as a “sink” for T4 because Mct8 ko mice
exhibited strongly increased renal T4 concentrations de-
spite the low serum T4 (17). However, Mct10/Mct8 dko
mice displayed highly elevated hepatic and renal D1 ex-
pression together with a further accumulation of TH in
liver and kidney. These findings indicate that the normal-
ization of serum T4 levels in Mct10/Mct8 dko mice is not
a consequence of a decreased hepatic and renal T4 uptake
andmetabolismand that further studies areneeded to fully
understand the tissue-specific role of these 2 transporters.
In summary, our data could support the notion that
Mct10 indeed acts as a TH transporter in vivo although its
contributiononly becomes evidentwhenMct8 as themost
prominent TH transporter is missing. In light of the seem-
ingly normal TH homeostasis in Mct10 ko mice, it is not
too surprising that patients carrying mutations in the
MCT10genehavenotbeen identified so far and that single
nucleotide polymorphisms in theMCT10 gene could not
be linked to alterations in serum TH levels (39, 40). Re-
markably, inactivation ofMct10 inMct8 komice resulted
in normal serum T4 levels and, consequently, ameliorated
the brain thyroidal state. At first glance, such an outcome
might be beneficial for patients with MCT8 mutations
because an increase in serum T4 may ultimately improve
the psychomotor development. However, normalization
of the serum T4 concentration is found only in the adult
Mct10/Mct8dkoanimals and thusoccurs too late to affect
neural differentiation processes. Moreover, our data
clearly indicate that, in the absence of both transporters,
the thyrotoxic situation in liver, kidney, and thyroid gland
becomes evenmorepronounced than in the singleMct8ko
mice. Consequently, the development of Mct10-specific
inhibitors does not appear to represent a possible thera-
peutic strategy to manipulate serum TH levels in patients
withMCT8mutations. Rather, further studies using con-
ditional Mct8 and Mct10 mouse mutants are needed to
shed light on the tissue-specific functionof theseTH trans-
porters aswell as on the exact pathogenicmechanisms that
underlie the development of the abnormal serum TH
profile.
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